128 kinds of medicine sampling in 15 days failed, Chinese medicine drink tablets and recruitment

[
dynamic pharmaceutical industry network Recently, Shandong Province Food and Drug Administration released drug quality sampling Notice (2020, No2), marking 10 manufacturers produce "Pulsatilla", "Bupleurum" "cicada" eight batches of 10 varieties of drugs, the sampling does not meet the standard requirementsIn this regard, Shandong Province Food and Drug Administration said that the relevant drug regulatory authorities to take non-compliant products have been sealed up, seized control measures to suspend sales, product recalls, and in accordance with relevant laws and regulations concerning the production enterprise (preparation of units), the sampling unit according to the law severely punishedis worth noting that, in addition to Shandong province, since May Yunnan, Hubei, Xinjiang also issued a series of drug quality announcement, a total of 128 have been traced to substandard drugs, involving 94 pharmaceutical companiesAmong them, the drug sampling unqualified list of mostly Chinese Herbal MedicineIn addition, it also found after combing, many were found to substandard pharmaceutical companies are "familiar face", repeatedly exposed throughout the Food and Drug Administration sampling failed drugsfact, in order to strengthen the quality supervision and management of drugs, standardize the market order, safeguard marketed drugs and drug packaging product quality and safety, in recent years under the impetus of the country, all over the Food and Drug Administration in Canada big production, operation and use of the drug unit mass sampling effortsIn the case of increasing the sampling base, substandard products will naturally increase, a number of pharmaceutical companies will also due to quality problems frequently namedaddition, the detected substandard products are mainly based Chinese Herbal MedicineWe know that many of thecultivation of Chinese herbal medicinestechnology is not mature, coupled with medicinal species deviations, defective processing technology, and other factors affect improperly stored, can lead to Chinese Herbal Medicine traits items non-compliance, and increase the probability of failure occurring in the samplingIn fact, public information, our current drug safety situation is generally stable and controllable drug quality remains at a high levelFor example, some time ago Report National Drug Research Institute test sampling Chinese food and drug released (2019) on the show in 2019, the national drug sampling completed a total of 184 varieties of 15612 batches of product sampling tasks, after testing non-compliant only 178 batches of products2018 year data also show, NDC 20890 sampling, sampling a total batch formulation product Upon examination, in line with the provisions of 20482 batches, 408 batches of non-compliance From the rate of qualified products, the steady improvement in the stage This also means that the overall quality of China's pharmaceutical quality control, security and stability Overall, the new "Drug Administration Law", the inspection of pharmaceutical products, penalties are increasing, and the trend was more and more stringent Thus, for pharmaceutical purposes, or to continue efforts to improve the quality of medicines in order to gain a foothold in increasingly stringent regulatory and increasingly brutal competition in the market.